|1.||Fraser, William D: 5 articles (10/2015 - 08/2010)|
|2.||Cheong, Jae Youn: 5 articles (12/2012 - 12/2010)|
|3.||Cho, Sung Won: 5 articles (12/2012 - 12/2010)|
|4.||Sale, Craig: 4 articles (10/2015 - 08/2010)|
|5.||Greeves, Julie P: 4 articles (10/2015 - 08/2010)|
|6.||Risteli, Juha: 4 articles (01/2015 - 11/2004)|
|7.||Greenspan, Daniel S: 4 articles (06/2014 - 07/2002)|
|8.||de la Piedra, Concepción: 4 articles (01/2014 - 05/2003)|
|9.||Kim, Dong Joon: 4 articles (12/2012 - 12/2010)|
|10.||Shah, Ajay M: 4 articles (11/2010 - 02/2006)|
09/01/2015 - "Before and after the 12-week training program, bone resorption (Telopeptidecrosslinked: β-CrossLaps) and bone formation (N-terminal propeptine of procollagen type 1: P1NP) including physiological and fitness data were assessed. "
03/01/2015 - "Tests included the bone resorption marker, C-terminal cross-linking telopeptide of type-1 collagen (CTX), and the bone formation marker procollagen type 1 N-terminal propeptide (P1NP). "
12/01/2014 - "In a phase 2 clinical trial, post-menopausal women receiving odanacatib presented a sustained reduction of bone resorption markers, whereas procollagen type 1 N-terminal propeptide returned to normal. "
07/28/2014 - "All participants underwent an oral glucose tolerance test (OGTT) after an overnight fast and serum levels of the bone resorption marker C-terminal crosslinking telopeptide of type I collagen (CTX-I) and the bone formation marker procollagen type I N propeptide were measured. "
12/01/2013 - "At baseline and after 3 and 6 months of training, blood samples were obtained to assess bone formation (serum procollagen type 1 N propeptide (PINP) and bone resorption (serum C-terminal telopeptide of type I collagen (CTX), and participants underwent dual-energy X-ray absorptiometry scans to obtain total body and regional estimates of bone mineral density (BMD). "
|2.||Body Weight (Weight, Body)
06/01/2014 - "Systolic blood pressure and body weight were measured at baseline and at the end of the study when left ventricular weight and ventricular expression of angiotensin I-converting enzyme and procollagen Iα1 were determined (polymerase chain reaction). "
01/01/2005 - "Pearson's r and multiple regression analysis were used to assess the relation between anthropometrics (weight, body mass index [BMI], percentage of body fat, fat-free weight, and fat freeBMI), biochemical markers, and bone mineral density (BMD) at the spine and femoral neck, as well as between BMD and each biochemical marker (serum bone formation marker procollagen amino-terminal propeptide [PINP],urinary bone resorption marker amino-terminal telopeptide [NTx], and the ratio of PINP to NTx. "
04/01/1992 - "Increases in "medullary" procollagen mRNA levels did not correlate with kidney weight, glomerular tuft volume, creatinine clearance, food intake, or body weight gain, and occurred when renal morphology was normal by light microscopy. "
12/01/1983 - "However, the infected liver procollagen prolyl hydroxylase activity decreased after administration of praziquantel 300 mg kg-1 body weight, and approached normal levels two weeks after treatment. "
07/25/1982 - "A reduction in collagen synthesis and procollagen mRNA was also observed in calvaria excised from 6-day-old rat pups given a single subcutaneous injection of 1,25-(OH)2D3 (1.6 ng/g body weight). "
03/01/2013 - "PG-PS-injected rats treated with anti-TNFα developed less intestinal fibrosis than vehicle-treated PG-PS-injected rats by tissue procollagen I (2.87 ± 0.66 versus 9.28 ± 1.11; P = 0.00002), procollagen III (2.25 ± 0.35 versus 7.28 ± 0.76; P = 0.0000009), and MT-MRI (MT ratio: 17.79 ± 1.61 versus 27.95 ± 1.75; P = 0.0001). "
11/01/2012 - "Time course of right ventricular pressure-overload induced myocardial fibrosis: relationship to changes in fibroblast postsynthetic procollagen processing."
05/01/2012 - "At later time points, the FD became progressively more extensive and severe, and this was associated with gene expression changes characteristic of tissue fibrosis, for example those associated with procollagen synthesis and processing. "
10/01/2009 - "Although not recognized at onset, skin biopsy showed typical histology of NSF affecting the entire dermis: CD34/procollagen I spindle cells associated with fibrosis. "
03/07/2007 - "On the other hand, the genes involved in the development of fibrosis, such as procollagen, Fn1, Eln, SMA, and Mmp9, Timp1 were significantly increased on day 5, not at 6h nor at 24h, after PQ treatment (the late marker). "
|4.||Neoplasm Metastasis (Metastasis)
01/01/2011 - "The marker of bone turnover procollagen type 1 aminoterminal propeptide can be considered as a useful tool for estimating the extent of bone involvement and for the detection of bone metastases. "
01/01/1996 - "Then, we calculated sensitivity, specificity, positive predictive value, negative predictive value and overall accuracy of procollagen and PSA in the detection of bone metastases. "
01/01/2011 - "The aim of this study was to show the importance of the bone marker procollagen type 1 aminoterminal propeptide (P1NP) in detecting bone metastases in women suffering from breast cancer. "
02/01/2009 - "The objective of this study was to assess the utility of the bone formation marker procollagen type 1 amino-terminal propeptide (P1NP) in indicating bone metastases in patients with prostate carcinoma. "
08/01/2014 - "Procollagen 1 amino-terminal propeptide (P1NP) is a bone formation marker and has been shown to have a strong association with the extent of bone metastases (BM) in patients with advanced prostate cancer. "
|5.||Liver Cirrhosis (Hepatic Cirrhosis)
04/20/2005 - "Radioimmunoassay method was used to examine the s serum index of liver fibrosis: HA, procollagen III (PCIII), LN, and CIV. "
05/15/2003 - "Predictive role of serum procollagen III peptide and Knodell's index in survival prognosis of patients with hepatitis B virus liver cirrhosis."
08/22/1997 - "We show that the enhancement of liver fibrosis is due, in part, to further upregulation in the expression of alpha1(I) procollagen and tissue inhibitor of metalloproteinases-1 mRNAs above values observed in control rats receiving only CCl4. "
08/16/1993 - "These findings indicate that oxidative reactions can directly influence procollagen I gene expression and synthesis in FSC, thus contributing to the development of liver fibrosis."
07/01/1989 - "Therefore, hepatocytes do not appear to be significantly involved in procollagen production in this experimental model of liver fibrosis."
|1.||Messenger RNA (mRNA)
|3.||Hyaluronic Acid (Hyaluronan)
|5.||Tissue Inhibitor of Metalloproteinase-1
|7.||Hydroxyproline (4 Hydroxyproline)
|8.||procollagen type I carboxy terminal peptide (PICP)
|9.||Biological Markers (Surrogate Marker)
|10.||Collagen Type IV (Type IV Collagen)
|1.||Drug Therapy (Chemotherapy)
|2.||Homologous Transplantation (Allograft)
|4.||Euthanasia (Mercy Killing)